Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Omar Pacha

Showing results (61-70 of 65) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 65 results.
Life (Basel, Switzerland)|November 27, 2025
Preoperative Risk Factors and Phenotypic Clustering in Periprosthetic Joint Infection: A Matched Case-Control StudyTarek Omar Pacha, Sophia K Klett, Gabi von Lewinski, et al.
Unfallchirurgie (Heidelberg, Germany)|February 6, 2023
[Interdisciplinary extremity board in the treatment of complex injuries]T Omar Pacha, P Mommsen, V Brauckmann, et al.
Journal of Cutaneous Pathology|June 27, 2018
Suprabasal acantholytic dermatologic toxicities associated checkpoint inhibitor therapy: A spectrum of immune reactions from paraneoplastic pemphigus-like to Grover-like lesionsWei-Shen Chen, Michael T Tetzlaff, Hafeez Diwan, et al.
Cancer|November 1, 2021
Cutaneous adverse events in 155 patients with metastatic melanoma consecutively treated with anti-CTLA4 and anti-PD1 combination immunotherapy: Incidence, management, and clinical benefitAnisha B Patel, Sahira Farooq, Macartney Welborn, et al.
Journal of Cutaneous Pathology|May 7, 2023
Gene expression profiling and multiplex immunofluorescence analysis of bullous pemphigoid immune-related adverse event reveal upregulation of toll-like receptor 4/complement-induced innate immune response and increased density of T<sub>H</sub> 1 T-cellsMario L Marques-Piubelli, Riyad N H Seervai, Kumaran M Mudaliar, et al.
Pageof 7

Showing results (61-70 of 65) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 65 results.
Life (Basel, Switzerland)|November 27, 2025
Preoperative Risk Factors and Phenotypic Clustering in Periprosthetic Joint Infection: A Matched Case-Control StudyTarek Omar Pacha, Sophia K Klett, Gabi von Lewinski, et al.
Unfallchirurgie (Heidelberg, Germany)|February 6, 2023
[Interdisciplinary extremity board in the treatment of complex injuries]T Omar Pacha, P Mommsen, V Brauckmann, et al.
Journal of Cutaneous Pathology|June 27, 2018
Suprabasal acantholytic dermatologic toxicities associated checkpoint inhibitor therapy: A spectrum of immune reactions from paraneoplastic pemphigus-like to Grover-like lesionsWei-Shen Chen, Michael T Tetzlaff, Hafeez Diwan, et al.
Cancer|November 1, 2021
Cutaneous adverse events in 155 patients with metastatic melanoma consecutively treated with anti-CTLA4 and anti-PD1 combination immunotherapy: Incidence, management, and clinical benefitAnisha B Patel, Sahira Farooq, Macartney Welborn, et al.
Journal of Cutaneous Pathology|May 7, 2023
Gene expression profiling and multiplex immunofluorescence analysis of bullous pemphigoid immune-related adverse event reveal upregulation of toll-like receptor 4/complement-induced innate immune response and increased density of T<sub>H</sub> 1 T-cellsMario L Marques-Piubelli, Riyad N H Seervai, Kumaran M Mudaliar, et al.
Pageof 7